CFO interim
Cadrenal Therapeutics, Inc. names Quang X. Pham interim CFO
Cadrenal Therapeutics, Inc. reported in a Form 8-K filed June 3, 2026 that Quang X. Pham was named interim Chief Financial Officer and interim Principal Accounting Officer, effective May 28, 2026.
In the filing's words
Effective immediately after Mr. Szot’s termination, the Company appointed Quang X. Pham, its Chief Executive Officer, as interim Chief Financial Officer and interim Principal Accounting Officer, to serve until a permanent Chief Financial Officer is appointed.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Cadrenal Therapeutics, Inc. (CVKD) |
|---|---|
| Event | Interim |
| Incoming | Quang X. Pham |
| Outgoing | Matthew K. Szot |
| Title in the filing | interim Chief Financial Officer and interim Principal Accounting Officer |
| Effective | May 28, 2026 |
| 8-K filed | June 3, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Chief Executive Officer, Cadrenal Therapeutics, Inc. |
| SEC CIK | 0001937993 |
Cadrenal Therapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed June 3, 2026. The filing's own words are quoted above.
Before and after at Cadrenal Therapeutics, Inc.
The adjacent records in the company's seat timeline.
Other records naming Quang X. Pham
1The incoming officer on this record, matched by name. Career line.
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
Same industry, June 2026
7Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
5 months ago· 2026-06-18InterimMPLT
MapLight Therapeutics, Inc. names Jonathan Gillis interim CFO
5 months ago· 2026-06-18TransitionPTPI
Petros Pharmaceuticals, Inc. CFO transition: Robert Weinstein to succeed Mitchell Arnold
5 months ago· 2026-06-15AppointmentSNSE
Sensei Biotherapeutics, Inc. appoints Brian Stephenson as CFO
5 months ago· 2026-06-12AppointmentOCUL
Ocular Therapeutix, Inc. appoints Jason Robins as CFO
5 months ago· 2026-06-04AppointmentBYSI
BeyondSpring Inc. appoints Na Li as CFO
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Quang X. Pham? Send a correction with the primary source.